Form: S-1

General form for registration of securities under the Securities Act of 1933

November 18, 2025

0001505497 EX-FILING FEES 0001505497 2025-11-18 2025-11-18 0001505497 1 2025-11-18 2025-11-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

EXHIBIT 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

BIORESTORATIVE THERAPIES, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities and Carry Forward Securities

 

    Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  

Amount

Registered

   Proposed
Maximum
Offering
Price Per
Share
   Maximum
Aggregate
Offering
Price
   Fee
Rate
   Amount of
Registration
Fee
   Carry
Forward
Form
Type
   Carry
Forward
File
Number
   Carry
Forward
Initial
Effective
Date
   Filing Fee
Previously
Paid In
Connection
with Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities 
Fees to Be
Paid
   Equity  Common
Stock,
par value
$0.0001
per share
   457 (o)  508,592 (1)   $1.30 (2)  $661,169.60    0.00013810   $91.31                                               
    Total Offering Amounts        $661,169.60       $91.31                     
    Total Fees Previously Paid                                        
    Total Fee Offsets                                        
    Net Fees Due                  $91.31                      

 

(1) Represents shares of common stock to be sold by the selling securityholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

 

(2) Calculated pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sale prices for our common stock as reported by the NASDAQ Capital Market on November 14, 2025.